Literature DB >> 7821363

Effect of adrenomedullin on renal hemodynamics and functions in dogs.

T Ebara1, K Miura, M Okumura, T Matsuura, S Kim, T Yukimura, H Iwao.   

Abstract

In order to elucidate the role of adrenomedullin in the kidney, we investigated the effects of adrenomedullin on renal hemodynamics and urine formation in anesthetized dogs. Intrarenal arterial infusion of adrenomedullin (0.8, 4 and 20 ng.kg-1.min-1) elicited dose-dependent increases in renal blood flow (by 10, 26 and 37%, respectively) with no change in blood pressure or heart rate, indicating a renal vasodilatory action of adrenomedullin. The glomerular filtration rate did not increase with the lower two doses, but increased marginally by 9% at the highest dose. Infusion of adrenomedullin at the rates of 4 and 20 ng.kg-1.min-1 increased urine flow and the urinary excretion of sodium and potassium dose dependently. Arterial and renal venous plasma renin activity was unaffected by adrenomedullin. These findings indicate that adrenomedullin is a potent renal vasodilatory peptide with a diuretic action. Since the threshold for the renal vasodilatory action of adrenomedullin is close to its physiological concentration in human plasma, adrenomedullin may play an important role in the regulation of renal function.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7821363     DOI: 10.1016/0014-2999(94)90524-x

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  14 in total

Review 1.  Adrenomedullin. Implications for hypertension research.

Authors:  K Kitamura; K Kangawa; H Matsuo; T Eto
Journal:  Drugs       Date:  1995-04       Impact factor: 9.546

2.  Adrenomedullin increases fluid extravasation from the splenic circulation of the rat.

Authors:  S Kaufman; P Andrew; R Sultanian; Y Deng
Journal:  J Physiol       Date:  2001-07-15       Impact factor: 5.182

3.  Plasma concentrations of adrenomedullin correlate with the extent of pulmonary hypertension in patients with mitral stenosis.

Authors:  T Nishikimi; S Nagata; T Sasaki; S Tomimoto; H Matsuoka; S Takishita; K Kitamura; A Miyata; H Matsuo; K Kangawa
Journal:  Heart       Date:  1997-10       Impact factor: 5.994

4.  Adrenomedullin expression in the human endometrium.

Authors:  J B Laoag-Fernandez; T Otani; T Maruo
Journal:  Endocrine       Date:  2000-02       Impact factor: 3.633

5.  Two molecular forms of adrenomedullin in congenital heart disease.

Authors:  K Watanabe; T Nishikimi; M Takamuro; K Yasuda; Y Ishikawa; S Tanabe; O Yamada; N Nagaya; H Matsuoka; K Kangawa; S Echigo
Journal:  Pediatr Cardiol       Date:  2003-09-04       Impact factor: 1.655

6.  Mid-regional pro-adrenomedullin is associated with pulse pressure, left ventricular mass, and albuminuria in African Americans with hypertension.

Authors:  Malik A Al-Omari; Mahyar Khaleghi; Thomas H Mosley; Stephen T Turner; Nils G Morgenthaler; Joachim Struck; Andreas Bergmann; Iftikhar J Kullo
Journal:  Am J Hypertens       Date:  2009-05-07       Impact factor: 2.689

7.  Attenuation of adrenomedullin-induced renal vasodilatation by NG-nitro L-arginine but not glibenclamide.

Authors:  K Miura; T Ebara; M Okumura; T Matsuura; S Kim; T Yukimura; H Iwao
Journal:  Br J Pharmacol       Date:  1995-07       Impact factor: 8.739

8.  Effects of calcitonin gene-related peptide receptor antagonists on renal actions of adrenomedullin.

Authors:  A M Elhawary; J Poon; C C Pang
Journal:  Br J Pharmacol       Date:  1995-08       Impact factor: 8.739

9.  Proadrenomedullin N-terminal 20 peptide inhibits adrenocorticotropin secretion from cultured pituitary cells, possibly via activation of a potassium channel.

Authors:  W K Samson; T C Murphy; Z T Resch
Journal:  Endocrine       Date:  1998-12       Impact factor: 3.925

10.  The usefulness of plasma levels of mature and total adrenomedullin as biomarkers indicating the magnitude of surgical stress responses: A single-center, prospective, observational study.

Authors:  Go Otao; Toyoaki Maruta; Tetsu Yonaha; Koji Igarashi; Sayaka Nagata; Kazuo Kitamura; Isao Tsuneyoshi
Journal:  J Clin Transl Res       Date:  2021-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.